Essential Healthcare News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Essential Healthcare News.

Press releases published on September 3, 2026

New AI BioDesign accelerator combines experimental biology and artificial intelligence to learn nature’s design rules
Cleanroom Technology Market to reach USD 21.55 Billion by 2035 at 7.26% CAGR
Oncology Drugs Market to reach USD 763.21 Billion by 2035 at 14.20% CAGR
Botulinum Toxin Market to reach USD 32.48 Billion by 2035 at 9.15% CAGR
Achieve Life Sciences Announced Granting of New Hire Inducement Awards
Inspiring Workplaces Group evolves Global Awards programme with the introduction of Inspiring Place to Work™
LogiQuip® and Lovell Announce Partnership to Expand Access to Healthcare Storage Solutions for VA, DoD, and IHS
Cytek® Biosciences Highlights the Expanding Role of Spectral Flow Cytometry in Clinical Research at ESCCA and ICCS
As AI reshapes business, Newsmatics teams up with Masaryk University to let students tackle real-world challenges
Clear Aligners Market to reach USD 26.88 Billion by 2035 at 18.2% CAGR
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
DBV Technologies annonce sa participation à plusieurs conférences investisseurs en septembre
DBV Technologies to Participate in Upcoming September Investor Conferences
Globus Medical Announces CE Mark for Excelsius3D™ Imaging System
Tenaya Therapeutics to Participate in Upcoming September Investor Conferences
New U.S. Treatment Recommendations Published for Severe Alopecia Areata in Adults
Dentsply Sirona to Participate in the Baird 2026 Global Healthcare Conference
Vivani Medical Announces Participation in Upcoming Investor Conferences
Canada’s Drug Agency Issues Recommendation to Reimburse Yorvipath® (palopegteriparatide injection) With Conditions for Eligible Adults With Chronic Hypoparathyroidism
L’Agence des médicaments du Canada recommande le remboursement de Yorvipathᴹᴰ (injection de palopegteriparatide), sous certaines conditions, pour les adultes admissibles atteints d’hypoparathyroïdie chronique.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Essential Healthcare News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.